Eric Jia-Sobota, Founder, Author at EverGlade Consulting

Eric Jia-Sobota, Founder

Eric Jia-Sobota is the National Leader of EverGlade’s Consulting Practice and the Founder of the Company. Eric’s consulting experience spans almost two decades across a breadth of industries, including, Federal Contracting, Life Sciences, Nonprofit, Technology, Construction, Healthcare, and others.

Eric Jia-Sobota, Co-Founder
BARDA advancing pathogen agnostic diagnostics

Advancing Pathogen-Agnostic Diagnostics

Leave a Comment / BARDA, Life Sciences / By

BARDA RRPV-26-09-AgDx Request for Project Proposals The Biomedical Advanced Research and Development Authority (BARDA) has released a new Request for Project Proposals (RPP-26-09-AgDx) through the Rapid Response Partnership Vehicle (RRPV), seeking to revolutionize the nation’s diagnostic readiness for infectious disease threats. Managed by Advanced Technology International (ATI), the RRPV enables collaboration between industry, academia, and […]

Advancing Pathogen-Agnostic Diagnostics Read More »

DARPA smart red cells program

DARPA’s Smart Red Blood Cells Program: Engineering the Future of Human Performance

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-26-02 (Smart Red Blood Cells Program) The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has announced a groundbreaking solicitation titled DARPA-PS-26-02: Smart Red Blood Cells (Smart-RBC) to redefine human performance in extreme environments. This program seeks to leverage advances in synthetic biology and bioengineering to create red blood cells (RBCs)

DARPA’s Smart Red Blood Cells Program: Engineering the Future of Human Performance Read More »

BARDA’s RPP to Onshore Vaccine Manufacturing for Viral Hemorrhagic Fevers

Leave a Comment / BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has issued a new Request for Project Proposals (RPP-26-10-VHF) under its Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium). This solicitation represents a key step in building domestic capacity for advanced vaccine manufacturing to strengthen the nation’s biosecurity infrastructure.

BARDA’s RPP to Onshore Vaccine Manufacturing for Viral Hemorrhagic Fevers Read More »

Medicine capsules global health with geometric pattern digital r

ARPA-H’s Proactive Health Office ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

PROACTIVE HEALTH OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-106 – Amendment 03: October 14, 2025 Building a Healthier Future Through Prevention The Advanced Research Projects Agency for Health (ARPA-H), a key innovation agency within the U.S. Department of Health and Human Services, has released an updated solicitation for its Proactive Health Office

ARPA-H’s Proactive Health Office ISO Read More »

DARPA Disruptioneering Program

DARPA’s Disruptioneering Program

Leave a Comment / DARPA, Emerging Technologies / By

DARPA Disruptioneering Program Announcement 25-07 The Defense Advanced Research Projects Agency (DARPA), through its Defense Sciences Office (DSO), has released its latest Disruptioneering Program Announcement (DARPA-PA-25-07). Published on September 30, 2025, this initiative aims to accelerate the agency’s ability to fund and execute high-risk, high-reward scientific research. At its core, the Disruptioneering program establishes a

DARPA’s Disruptioneering Program Read More »

DARPA’s Biological Technologies Office Broad Agency Announcement

Leave a Comment / DARPA, Emerging Technologies / By

DARPA BTO Broad Agency Announcement 10.25 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released a new Broad Agency Announcement (BAA), HR001126S0003, on October 1, 2025. This solicitation seeks transformative research leveraging biological processes and technologies to enhance warfighter protection and performance. DARPA BTO continues to push the boundaries

DARPA’s Biological Technologies Office Broad Agency Announcement Read More »

HHS Operations During A Government Shutdown

Leave a Comment / ARPA-H, ASPR-IBx, BARDA, Life Sciences / By

When the federal government faces a lapse in appropriations, agencies across the Department of Health and Human Services (HHS) must implement contingency plans to sustain critical activities. Both the Advanced Research Projects Agency for Health (ARPA-H) and the Administration for Strategic Preparedness and Response (ASPR), which houses the Biomedical Advanced Research and Development Authority (BARDA),

HHS Operations During A Government Shutdown Read More »

ARPA-H THRIVE ISO with Amendment 4

Leave a Comment / ARPA-H, Life Sciences / By

Last Updated: November 17, 2025 Important Update to Timeline and Submission Requirements (Step 2: PowerPoint Presentation Submission Requirements) THRIVE+ISO_Amendment+4 (2) Transforming Genetic Medicine for Rare Diseases: ARPA-H’s THRIVE Initiative The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Office, has announced the Treating Hereditary Rare diseases with In Vivo precision genetic

ARPA-H THRIVE ISO with Amendment 4 Read More »

ARPA-H GIVE Initiative to Transform Genetic Medicine Manufacturing

Leave a Comment / ARPA-H, Life Sciences / By

ARPA-H 4.0_GIVE_ISO_20250925 Revolutionizing Biomanufacturing for Personalized Genetic Medicines The Advanced Research Projects Agency for Health (ARPA-H), through its Scalable Solutions Office (SSO), has released an Innovative Solutions Opening (ISO) titled Genetic Medicines and Individualized Manufacturing for Everyone (GIVE). This bold initiative seeks to accelerate U.S. leadership in biomanufacturing by enabling distributed, on-demand, and individualized production

ARPA-H GIVE Initiative to Transform Genetic Medicine Manufacturing Read More »

Advancing Biodefense Readiness: MTEC and DTRA’s Multi-Topic RPP

Leave a Comment / DTRA, Life Sciences, MTEC / By

In September 2025, the Medical Technology Enterprise Consortium (MTEC), in partnership with the Defense Threat Reduction Agency (DTRA), announced a new Request for Project Proposals (RPP) aimed at accelerating U.S. biodefense capabilities. The solicitation, “Advancing Biodefense Readiness: On-Demand Biologics, Automated Threat Detection, and Alternatives for Testing Medical Countermeasures in High Containment,” seeks applied prototype solutions

Advancing Biodefense Readiness: MTEC and DTRA’s Multi-Topic RPP Read More »

US_UK Technology Prosperity Deal

The U.S.–U.K. Technology Prosperity Deal: A Strategic Framework for Shared Innovation

Leave a Comment / All Posts, Emerging Technologies / By

On September 18, 2025, the Governments of the United States and the United Kingdom signed a Memorandum of Understanding Between the Government of the United States of America and the Government of the United Kingdom of Great Britain and Northern Ireland Regarding the Technology Prosperity Deal. This MOU reflects both countries’ commitment to partnering on

The U.S.–U.K. Technology Prosperity Deal: A Strategic Framework for Shared Innovation Read More »

DARPA’s MASH Program: Autonomous Trauma Care for the Battlefield

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-25-34 (2) Medics Autonomously Stopping Hemorrhage (MASH) The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has announced the Medics Autonomously Stopping Hemorrhage (MASH) program (DARPA-PS-25-34). This initiative targets one of the leading causes of preventable battlefield deaths: non-compressible torso hemorrhage (NCTH). With nearly a quarter of combat fatalities in recent

DARPA’s MASH Program: Autonomous Trauma Care for the Battlefield Read More »

Scroll to Top